The Role of Ketamine Infusion for Patients with MS-Related Fatigue

Discussion in 'Other health news and research' started by Jaybee00, Nov 4, 2020.

  1. Jaybee00

    Jaybee00 Senior Member (Voting Rights)


    Primary outcome of the study was negative.


    Fitzgerald KC, Morris B, Soroosh A, et al. Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis–related fatigue. Mult Scler. Published online July 7, 2020. doi:10.1177/1352458520936226

Share This Page